Adenosine Receptor Agonist HE-NECA Enhances Antithrombotic Activities of Cangrelor and Prasugrel in vivo by Decreasing of Fibrinogen Density in Thrombus

Blood platelets’ adenosine receptors (AR) are considered to be a new target for the anti-platelet therapy. This idea is based on in vitro studies which show that signaling mediated by these receptors leads to a decreased platelet response to activating stimuli. In vivo evidence for the antithromboti...

Descripción completa

Detalles Bibliográficos
Autores principales: Polak, Dawid, Talar, Marcin, Wolska, Nina, Wojkowska, Dagmara W., Karolczak, Kamil, Kramkowski, Karol, Bonda, Tomasz A., Watala, Cezary, Przygodzki, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002731/
https://www.ncbi.nlm.nih.gov/pubmed/33802928
http://dx.doi.org/10.3390/ijms22063074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002731/
https://www.ncbi.nlm.nih.gov/pubmed/33802928
http://dx.doi.org/10.3390/ijms22063074

Ejemplares similares